Determine the necessary mass, volume, or concentration for preparing a solution.
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
SKU | Size | Availability | Price | Qty |
---|---|---|---|---|
L122339-10mg | 10mg | Available within 4-8 weeks(?) Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience! | $53.90 | |
L122339-50mg | 50mg | Available within 4-8 weeks(?) Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience! | $205.90 | |
L122339-200mg | 200mg | Available within 4-8 weeks(?) Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience! | $423.90 | |
L122339-1g | 1g | Available within 4-8 weeks(?) Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience! | $1,908.90 | |
L122339-5g | 5g | Available within 4-8 weeks(?) Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience! | $8,586.90 |
CaV1.x blocker
Synonyms | Lercanidipine hydrochloride|132866-11-6|Lercanidipine HCl|Cardiovasc|Corifeo|Carmen|Lercadip|Lerzam|Lercan|LERCANIDIPINEHCL|Rec-15/2375|Lercanidipine (hydrochloride)|100427-27-8|3-(1-((3,3-diphenylpropyl)(methyl)amino)-2-methylpropan-2-yl) 5-methyl 2,6-di |
---|---|
Specifications & Purity | ≥98%(HPLC) |
Biochemical and Physiological Mechanisms | L-type Ca2+channel blocker that displays higher vascular selectivity than felodipine. Causes peripheral vasodilation with only weak negative inotropic activity. Antihypertensive. Also exhibits anti-MERS-CoV activity in Vero cellsin vitro(IC50= 2.36 μM). |
Storage Temp | Store at 2-8°C |
Shipped In | Wet ice |
Action Type | BLOCKER |
Mechanism of action | Voltage-gated L-type calcium channel blocker |
Note | 200mg、1g、10mg卖完停产,不再备货 |
Product Description | Lercanidipine hydrochloride is a L-type (Cav1.2b) vascular channel antagonist; L-type (Cav1.2a) cardiac channel agonist voltage-dependent and highly lipophylic compound, which exhibits a slower onset and longer duration of action than other calcium channel antagonists; an antihypertensive agent in patients with mild-to-moderate hypertension; more vasoselective than lacidipine and amlodipine . |
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
IUPAC Name | 5-O-[1-[3,3-diphenylpropyl(methyl)amino]-2-methylpropan-2-yl] 3-O-methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate;hydrochloride |
---|---|
INCHI | InChI=1S/C36H41N3O6.ClH/c1-24-31(34(40)44-6)33(28-18-13-19-29(22-28)39(42)43)32(25(2)37-24)35(41)45-36(3,4)23-38(5)21-20-30(26-14-9-7-10-15-26)27-16-11-8-12-17-27;/h7-19,22,30,33,37H,20-21,23H2,1-6H3;1H |
InChi Key | WMFYOYKPJLRMJI-UHFFFAOYSA-N |
Canonical SMILES | CC1=C(C(C(=C(N1)C)C(=O)OC(C)(C)CN(C)CCC(C2=CC=CC=C2)C3=CC=CC=C3)C4=CC(=CC=C4)[N+](=O)[O-])C(=O)OC.Cl |
Isomeric SMILES | CC1=C(C(C(=C(N1)C)C(=O)OC(C)(C)CN(C)CCC(C2=CC=CC=C2)C3=CC=CC=C3)C4=CC(=CC=C4)[N+](=O)[O-])C(=O)OC.Cl |
WGK Germany | 3 |
PubChem CID | 157917 |
UN Number | 2811 |
Molecular Weight | 657.2 |
Enter Lot Number to search for COA:
To view the certificate results,please click on a Lot number.For Lot numbers from past orders,please use our order status section
Lot Number | Certificate Type | Date | Item |
---|---|---|---|
J1515147 | Certificate of Analysis | Jul 07, 2023 | L122339 |
D2320771 | Certificate of Analysis | Mar 15, 2023 | L122339 |
D2320827 | Certificate of Analysis | Mar 15, 2023 | L122339 |
D2321125 | Certificate of Analysis | Mar 15, 2023 | L122339 |
D2321127 | Certificate of Analysis | Mar 15, 2023 | L122339 |
D2321760 | Certificate of Analysis | Mar 15, 2023 | L122339 |
H1806053 | Certificate of Analysis | Jun 14, 2022 | L122339 |
Solubility | Solvent:DMSO, Max Conc. mg/mL: 64.82, Max Conc. mM: 100; Solvent:ethanol, Max Conc. mg/mL: 6.48, Max Conc. mM: 10 |
---|---|
Sensitivity | Light and Moisture Sensitive |
Melt Point(°C) | 195 °C(dec.) |
Pictogram(s) | GHS06, GHS07 |
---|---|
Signal | Danger |
Hazard Statements | H301:Toxic if swallowed H302:Harmful if swallowed |
Precautionary Statements | P321:Specific treatment (see ... on this label). P405:Store locked up. P501:Dispose of contents/container to ... P264:Wash hands [and …] thoroughly after handling. P270:Do not eat, drink or smoke when using this product. P330:Rinse mouth. P301+P316:IF SWALLOWED: Get emergency medical help immediately. P301+P317:IF SWALLOWED: Get medical help. |
WGK Germany | 3 |
Merck Index | 5446 |